Skip to main content
Clinical Trials/NCT04010006
NCT04010006
Unknown
Not Applicable

Randomized Controlled Trials Comparing Clinical Outcome of HD Versus 4K Laparoscopy for Gastric Cancer(FUGES-017)

Fujian Medical University1 site in 1 country502 target enrollmentJuly 15, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stomach Neoplasms
Sponsor
Fujian Medical University
Enrollment
502
Locations
1
Primary Endpoint
operating time
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to explore the feasibility of 4K Laparoscopic Surgery for Gastric Cancer.

Detailed Description

A prospective randomized comparison of HD and 4K laparoscopic surgery for gastric cancer will be performed, to evaluate the clinical value and provide theoretical basis and clinical experience for the extensive application of the 4K laparoscopic technique. The evaluation parameters are perioperative clinical efficacy, postoperative life quality, immune function and 3-year survival and recurrence rates.

Registry
clinicaltrials.gov
Start Date
July 15, 2019
End Date
July 15, 2023
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fujian Medical University
Responsible Party
Principal Investigator
Principal Investigator

Chang-Ming Huang, Prof.

Director, Head of gastric surgery, Principal Investigator, Clinical Professor

Fujian Medical University

Eligibility Criteria

Inclusion Criteria

  • (1)Age from over 19 to under 74 years
  • (2)cT 1-4a(clinical stage tumor), N0-3, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition
  • (3)Heart, lungs, kidneys and other vital organs function well, with no obvious surgical contraindications
  • (4)Preoperative examination with no distant metastasis, no significantly enlarged lymph nodes around abdominal main artery, and tumor not a direct violation of the pancreas, spleen and other surrounding organs
  • (5)American Society of Anesthesiology (ASA) score class I, II, or III
  • (6)Written informed consent

Exclusion Criteria

  • (1)Women during pregnancy or breast-feeding
  • (2)Severe mental disorder
  • (3)History of previous upper abdominal surgery (except laparoscopic cholecystectomy)
  • (4)Enlarged splenic hilar lymph nodes with integration into a mass and surrounding the blood vessels
  • (5)History of unstable angina or myocardial infarction within past six months
  • (6)History of cerebrovascular accident within past six months
  • (7)History of continuous systematic administration of corticosteroids within one month
  • (8)History of previous neoadjuvant chemotherapy or radiotherapy
  • (9)T4b tumors
  • (10)Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer

Outcomes

Primary Outcomes

operating time

Time Frame: 1 day

day

Secondary Outcomes

  • Time to first soft diet(10 days)
  • intracavitary anastomosis time(1 day)
  • the number of positive lymph nodes(1 day)
  • intraoperative lymph node dissection time(1 day)
  • intraoperative blood loss(1 day)
  • the amount of use of titanium clip(1 day)
  • duration of postoperative hospital stay(10 days)
  • 3-year overall survival rate(36 months)
  • Time to first ambulation(10 days)
  • Time to first flatus(10 days)
  • Complication(30 days;36 months)
  • The number of lymph node dissection(1 day)
  • intraoperative injury(1 day)
  • Hospitalization expenses(1 months)
  • Time to first liquid diet(10 days)
  • the rate of conversion to laparotomy(1 day)
  • The daily highest body temperature before discharge(7 days)
  • Overall postoperative morbidity and mortality rates(30 days)
  • 3-year disease free survival rate(36 months)

Study Sites (1)

Loading locations...

Similar Trials